Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease

In 2010, the National Institutes of Health (NIH) established the Therapeutics for Rare and Neglected Diseases (TRND) program within the National Center for Advancing Translational Science (NCATS), which was created to stimulate drug discovery and development for rare and neglected tropical diseases...

詳細記述

保存先:
書誌詳細
主要な著者: Ottinger, Elizabeth A., Kao, Mark L., Carrillo-Carrasco, Nuria, Yanjanin, Nicole, Shankar, Roopa Kanakatti, Janssen, Marjo, Brewster, Marcus, Scott, Ilona, Xu, Xin, Cradock, Jim, Terse, Pramod, Dehdashti, Seameen, Marugan, Juan, Zheng, Wei, Portilla, Lili, Hubbs, Alan, Pavan, William J., Heiss, John, Vite, Charles H., Walkley, Steven U., Ory, Daniel S., Silber, Steven A., Porter, Forbes D., Austin, Christopher P., McKew, John C.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4048128/
https://ncbi.nlm.nih.gov/pubmed/24283970
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料